Sep 28, 2023 / 06:25PM GMT
Pete Stavropoulos - Cantor Fitzgerald & Co. - Analyst
Welcome to the Cantor Global Healthcare Conference, I'm Pete Stavropoulos, biotech analyst with Cantor. With us, we have Vaxart and I'm pleased to introduce Andrei Floroiu, CEO; and James Cummings, CMO.
Vaxart is a company that we do cover the or vaccine focused company with a platform that's designed to stimulate mucosal immunity. So a very unique platform called VAAST. So with that, welcome I you.
James Cummings - Vaxart, Inc. - Chief Medical Officer
Thanks.
Andrei Floroiu - Vaxart, Inc. - President & CEO
Thank you so much. We're happy to be here. So I guess we'll show you a few slides and then Pete ask us questions. (multiple speakers) -- Yeah.
Forward-looking statements. All investors should go through this, not going to spend too much time on them. This is an executive summary, but I'll spend more time on it at the end, just go into into what we're here to talk about.
And what we're here to talk about is how can Vaxart
Vaxart Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 28, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers